Ovarian failure, do I have any chance of getting pregnant?
The ovaries perform two very important functions throughout a woman's life: the first is the secretion of hormones that allow the development of female sexual organs and characteristics, and the second is the reproductive function, whereby, thanks to the maturation of the eggs in the ovaries, women can ovulate and become pregnant cyclically from puberty onward. Ovarian failure will reduce the chances of getting pregnant. Beatriz Álvaro Mercadal explains the consequences of premature ovarian insufficiency in this article.
The average age of physiological menopause is 50-51 years, although it can occur as early as 40. When it happens between 40 and 45 years of age, it is called early menopause, and when it happens before 40, it is called premature ovarian insufficiency.
Premature ovarian insufficiency (POI), formerly known as ovarian failure or early menopause, is defined as the absence of menstruation for four months or more, with specific blood tests showing excessively high levels of follicle-stimulating hormone (FSH) and very low levels of estradiol. This indicates that the absence of menstruation is directly related to an ovarian problem. Despite receiving stimulation from FSH, the ovary does not respond as it should; ovulation does not occur, and hormones are not secreted correctly (hence the low estradiol level).
This has two consequences that can be significant for a woman's overall and reproductive health. The absence of eggs in the ovaries prevents her from having children using her own eggs and genetic material. Furthermore, the lack of necessary hormones increases the risk of osteoporosis, cardiovascular events, and symptoms related to estrogen deficiency, such as vaginal and mucous membrane dryness and hot flashes.
Why does ovarian failure occur?
The reason this occurs is unknown in most cases. Sometimes it is due to genetic, autoimmune (the body produces antibodies against certain tissues of its own body), infectious causes, or to having received ovarian surgery, chemotherapy, or radiation therapy.
What can we do in response to this diagnosis?
It is important to seek specialized guidance and psychological support because the cessation of ovarian function is a sensitive issue for most women. It is essential to be well-informed about the risks and consequences of estrogen deficiency. Therefore, even if there is no desire to conceive, hormonal treatment should be considered to replace what the body should produce until age 50-51. Hormone replacement therapy appears to decrease the likelihood of developing osteoporosis, cardiovascular events, and even mortality.
If I want to have children, what options do I have?
In women who wish to have children and are diagnosed with premature ovarian insufficiency, the lifetime probability of spontaneous pregnancy is approximately 51%. While ovarian function can resume, it is unpredictable; it is impossible to know when this will happen, and there are currently no treatments that can promote ovulation in these cases.
Treatments that attempt to stimulate the ovary with high doses of medication (gonadotropins) do not achieve better rates than those of spontaneous pregnancy already described, since the ovary with ovarian insufficiency does not respond to stimulation treatment.
To achieve pregnancy, the only validated option at present is in vitro fertilization (IVF) with donor eggs. This option significantly increases the chances of pregnancy, to approximately 45-50% per embryo transfer, or approximately 70-80% per cycle (once all embryos obtained in the same IVF cycle have been transferred).
It is true that some teams are conducting studies on promising new treatments to obtain fertilizable eggs and pass on one's own genetic material to offspring. Autologous stem cell transplantation, in vitro or mechanical activation of ovarian tissue followed by autologous transplantation, and egg retrieval from skin cells are some examples of what is currently being studied. But for now, these are all experimental techniques that should only be carried out within the framework of research studies.

Can early ovarian insufficiency be predicted?
Between 5 and 15% cases are familial and probably have an associated genetic factor, in most cases unknown.
Today, there are markers that allow us to assess the risk of developing ovarian insufficiency. Some blood markers, such as anti-Müllerian hormone (AMH), and ultrasound markers, such as antral follicle count (AFC), allow us to know the state of the ovaries at a specific time and relate it to what would be expected for the patient's age. When AMH and/or AFC are too low, there is a risk of primary ovarian insufficiency (POI). In the female offspring of a woman with ovarian insufficiency, it is recommended to have an ovarian reserve assessment performed at the beginning of adulthood.
Although attempts have been made to develop tables to predict the age of menopause, these are still not accurate enough, and the mother's age at menopause remains the most decisive predictive factor.
Can ovarian insufficiency be prevented?
Among the environmental factors that have been shown to influence the earlier onset of menopause is smoking. Endocrine disruptors (such as BPA or Bisphenol A) may play a role in the development of premature ovarian failure, but this has not yet been clearly demonstrated.
Certain cases at risk of developing POI can benefit from oocyte or ovarian tissue preservation. This is the case, for example, for patients who know they are carriers of a genetic disease (such as Fragile X premutation or a karyotype abnormality), who must undergo surgical treatment for severe endometriosis, or who must undergo radiotherapy to treat cancer. The procedure does not prevent POI, but it can be an additional option for the future reproduction of these women who have a high probability of not being able to conceive with their own eggs without prior treatment.

